TBI vs MAN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

TBI

58.5
AI Score
VS
MAN Wins

MAN

61.9
AI Score

Investment Advisor Scores

TBI

Oct 02, 2026
59score
Recommendation
HOLD

MAN

Oct 02, 2026
62score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric TBI MAN Winner
Forward P/E 11.2994 11.7647 TBI
PEG Ratio 0.8068 0.943 TBI
Revenue Growth 11.8% 7.5% TBI
Earnings Growth -63.4% -58.2% MAN
Tradestie Score 58.5/100 61.9/100 MAN
Profit Margin -3.4% 0.6% MAN
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

TBI 1M: -10.3% · 3M: +12.0% MAN 1M: -10.6% · 3M: +40.2%

Current Technical Phase

TBI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $9.15

MAN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 36.5 · Price: $53.90

Fundamentals Snapshot

Metric TBI MAN
Market Cap — —
Forward P/E 11.6 11.6
Trailing P/E — 25.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.2%
Operating Margin 0.0% 0.0%
EPS -1.92 2.18
Dividend Yield — 0.03%

Frequently Asked Questions

Based on our detailed analysis, MAN is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.